Welcome to
Scandinavian Biopharma

Scandinavian Biopharma is a Swedish research-based biotech company specialist in marketing and sales of vaccines, dental products and immunoglobulins to the Nordic market.

Research and development is mainly focused on development of a new oral traveler’s diarrhea vaccine in collaboration with PATH Vaccine Solutions and University of Gothenburg.


Scandinavian Biopharma is expanding by hiring a PhD in cell- and molecular biology

2017-03-07

We are happy to announce that Teresa Holmlund has joined us. Teresa has a PhD in cell and molecular biology and ten years of academic research experience studying molecular mechanisms in mitochondrial disease, cancer and severe congenital neutropenia. – It feels great to be a part of Scandinavian Biopharma. It’s really motivating to work with […]

All 450 participants starting from adults down to 6 months young infants are enrolled in our study in Bangladesh

2017-02-27

One and a half year ago a phase I/II randomized, double-blind, placebo-controlled trial was started in Dhaka, Bangladesh. All 450 participants have now been enrolled and the last child received the vaccine this February. This clinical trial is the first important step toward showing that our vaccine can protect children in the developing world against […]

We are proud!

2016-07-06

We are a part of the global movement to defeat diarrheal disease. That makes us proud! https://www.youtube.com/watch?feature=player_embedded&v=80POTZN88Ho